137 related articles for article (PubMed ID: 1617932)
1. A randomized double-blind controlled trial of roxithromycin and cefaclor in the treatment of acute lower respiratory tract infections in general practice.
Tilyard MW; Dovey SM
Diagn Microbiol Infect Dis; 1992; 15(4 Suppl):97S-101S. PubMed ID: 1617932
[TBL] [Abstract][Full Text] [Related]
2. A multicentre trial of cefaclor advanced formulation versus cefaclor in the treatment of acute bronchitis.
Alanis A; Longest KA; Senetar JE; Dere WH
Postgrad Med J; 1992; 68 Suppl 3():S24-8, discussion S29. PubMed ID: 1287614
[TBL] [Abstract][Full Text] [Related]
3. Multicenter evaluation of azithromycin and cefaclor in acute lower respiratory tract infections.
Dark D
Am J Med; 1991 Sep; 91(3A):31S-35S. PubMed ID: 1656740
[TBL] [Abstract][Full Text] [Related]
4. Treatment of acute bacterial bronchitis and pneumonia with cefaclor.
Mogabgab WJ; Pollock B; Beville RB; Gentry LO; Jemsek JG
Postgrad Med J; 1979; 55 Suppl 4():62-6. PubMed ID: 44908
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, safety and tolerability of azithromycin versus roxithromycin in the treatment of acute lower respiratory tract infections.
Laurent K
J Antimicrob Chemother; 1996 Jun; 37 Suppl C():115-24. PubMed ID: 8818852
[TBL] [Abstract][Full Text] [Related]
6. Interrelationship between the pharmacokinetics and pharmacodynamics of cefaclor advanced formulation in patients with acute exacerbation of chronic bronchitis.
Cazzola M; Di Perna F; Boveri B; Di Marco F; Diamare F; Centanni S
J Chemother; 2000 Jun; 12(3):216-22. PubMed ID: 10877516
[TBL] [Abstract][Full Text] [Related]
7. Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group.
Fong IW; Laforge J; Dubois J; Small D; Grossman R; Zakhari R
Clin Invest Med; 1995 Apr; 18(2):131-8. PubMed ID: 7788958
[TBL] [Abstract][Full Text] [Related]
8. Randomized comparative study of ceftibuten versus cefaclor in the treatment of acute lower respiratory tract infections.
Kammer RB; Ress R
Diagn Microbiol Infect Dis; 1991; 14(1):101-5. PubMed ID: 2013204
[TBL] [Abstract][Full Text] [Related]
9. Roxithromycin versus doxycycline in the treatment of acute exacerbations of chronic bronchitis.
De Vlieger A; Druart M; Puttemans M
Diagn Microbiol Infect Dis; 1992; 15(4 Suppl):123S-127S. PubMed ID: 1617923
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis.
Gotfried MH; Ellison WT
Am J Med; 1992 Apr; 92(4A):108S-113S. PubMed ID: 1316059
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacies of erythromycin-sulfisoxazole and cefaclor in acute otitis media: a double blind randomized trial.
Bergeron MG; Ahronheim G; Richard JE; Riding K; Cron C; Bryer D; Macdonald N; Bouchard M; Young J; Dempsey EE
Pediatr Infect Dis J; 1987 Jul; 6(7):654-60. PubMed ID: 3302918
[TBL] [Abstract][Full Text] [Related]
12. Cefaclor AF: correlation of microbiology and clinical outcome.
Thornsberry C
Postgrad Med J; 1992; 68 Suppl 3():S10-6. PubMed ID: 1287612
[TBL] [Abstract][Full Text] [Related]
13. Cefaclor advanced formulation versus cefaclor in the treatment of pneumonia.
Casali L; Voi M; Janssen CJ; Olovich KG; Dere WH
Clin Ther; 1992; 14(4):570-7. PubMed ID: 1525791
[TBL] [Abstract][Full Text] [Related]
14. Roxithromycin versus cefaclor in lower respiratory tract infection: a general practice pharmacoeconomic study.
Scott WG; Tilyard MW; Dovey SM; Cooper B; Scott HM
Pharmacoeconomics; 1993 Aug; 4(2):122-30. PubMed ID: 10146972
[TBL] [Abstract][Full Text] [Related]
15. Cefaclor in the treatment of infective exacerbations of chronic bronchitis in cigarette smokers.
Cazzola M; Franco C; Gioia V; Legnani D; Mancini V; Polverino M; Sevieri G
J Chemother; 1991 Aug; 3(4):245-9. PubMed ID: 1779259
[TBL] [Abstract][Full Text] [Related]
16. Swedish Study Group. A randomized multicenter trial to compare the influence of cefaclor and amoxycillin on the colonization resistance of the digestive tract in patients with lower respiratory tract infection.
Infection; 1991; 19(4):208-15. PubMed ID: 1917031
[TBL] [Abstract][Full Text] [Related]
17. Double-blind comparison of cefixime and cefaclor in the treatment of acute otitis media in children.
Piippo T; Stefansson S; Pitkäjärvi T; Lundberg C
Scand J Infect Dis; 1991; 23(4):459-65. PubMed ID: 1957129
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of cefuroxime axetil and cefaclor for treatment of acute bacterial maxillary sinusitis.
Sydnor A; Gwaltney JM; Cocchetto DM; Scheld WM
Arch Otolaryngol Head Neck Surg; 1989 Dec; 115(12):1430-3. PubMed ID: 2510772
[TBL] [Abstract][Full Text] [Related]
19. Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis.
Kaiser L; Morabia A; Stalder H; Ricchetti A; Auckenthaler R; Terrier F; Hirschel B; Khaw N; Lacroix JS; Lew D
Eur J Clin Microbiol Infect Dis; 2001 Jul; 20(7):445-51. PubMed ID: 11561799
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy and safety evaluation of cefaclor vs amoxycillin + clavulanate in children with Acute Otitis Media (AOM).
Aggarwal M; Sinha R; Murali MV; Trihan P; Singhal PK
Indian J Pediatr; 2005 Mar; 72(3):233-8. PubMed ID: 15812119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
